Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
08.05.Teva plots thousands of job cuts as restructuring drive enters 'acceleration' phase
08.05.Gilead tees up $11B in new US manufacturing, R&D investments
07.05.Moderna faces PMCPA audit over 'completely unacceptable' lack of transparency
07.05.J&J survey finds pace of oncology innovation is overwhelming physicians
07.05.AstraZeneca, Daiichi Sankyo's Enhertu rings up success in another breast cancer trial
07.05.Xellia to shutter Copenhagen antibiotics plant, dealing a blow to EU reshoring efforts
07.05.Novo's Wegovy takes a hit from compounders, but company expects faster second-half growth
06.05.Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia
06.05.FDA commissioner Marty Makary taps Vinay Prasad to head up CBER
06.05.Neurocrine holds on to branded tardive dyskinesia push with help from Wilson Phillips star
06.05.'Now is not the time to retreat': BMS CEO blasts Trump admin tariffs, health reforms amid $40B US investment pledge
06.05.Trump signs executive order to boost US drug manufacturing amid threat of tariffs
06.05.Incyte, Novartis agree to settle long-running Jakafi royalty dispute just before trial
06.05.Havas Life opens Dubai office to serve 'thriving' Middle East and North Africa region
06.05.AstraZeneca debuts $300M cell therapy manufacturing facility in Maryland
05.05.Ex-Moderna brand chief Kate Cronin joins Medtronic Diabetes as marketing head
05.05.US net drug spending surged 11.4% last year, boosted by obesity and oncology meds: IQVIA
05.05.AbbVie's Skyrizi retakes top TV ad spending spot for the first time all year
05.05.BioNTech, gearing up for cancer drug approval filing, works to diversify supply base
02.05.AstraZeneca's Breztri aces 2 asthma trials, lining it up for label expansion
02.05.BMS scales back at former Novartis plant, shifting cell therapy vector production to MA
02.05.Almirall, Biofrontera encourage sun protection in actinic keratosis social media challenge
02.05.Madrigal's Rezdiffra, the first-ever MASH drug, beats sales projections for 4 quarters in a row
02.05.As Amgen's trio of Horizon drugs disappoints, execs urge analysts to give them more time
02.05.Regulatory tracker: AbbVie's Rinvoq scores 9th FDA nod, this time in GCA